"Our agreement with Mundipharma is a key milestone for Nitec as we prepare for a European launch. Mundipharma has a proven track record in successfully launching and commercialising pharmaceutical products in Europe. Their strength, as a partner is their strong expertise with the target prescribers in these key markets. We are confident that this agreement with Mundipharma’s highly committed and specialised sales force will accelerate Lodotra®’s market success. Personally, I strongly believe that our two companies will cooperate effectively as we share values and an entrepreneurial philosophy."
Dr Anders Härstrand, CEO of Nitec Pharma AG
Nitec has been acquired by Horizon AG